Spinal Muscular Atrophy (SMA) Treatment Market Size, Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI100576

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Spinal Muscular Atrophy for Key Countries
2. Key Industry Developments
3. Pipeline Analysis
4. New Product Launches
5. Reimbursement Scenario by Key Countries
6. Regulatory Scenario
7. Key Industry Trends
Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis, Insights and Forecast – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country/ sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Rest of Europe
Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country/ sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles
  1. Biogen
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Novartis AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Genentech, Inc./ F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Astellas Pharma Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. Genzyme Corporation
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Spinal Muscular Atrophy for Key Countries
2. Key Industry Developments
3. Pipeline Analysis
4. New Product Launches
5. Reimbursement Scenario by Key Countries
6. Regulatory Scenario
7. Key Industry Trends
Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis, Insights and Forecast – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country/ sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Rest of Europe
Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
5. Market Analysis – By Country/ sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Product Type
  1. Nusinersen
  2. Onasemnogen Abeparvovec
3. Market Analysis – By Disease Type
  1. Type 1 SMA
  2. Type 2 SMA
  3. Others
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Others
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles
  1. Biogen
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Novartis AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Genentech, Inc./ F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Astellas Pharma Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. Genzyme Corporation
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)

Read Less

List of Figures

Figure 1: Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034

Figure 2: Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Nusinersen, 2025-2034

Figure 4: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Onasemnogen Abeparvovec, 2025-2034

Figure 5: Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2025 & 2034

Figure 6: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 1 SMA, 2025-2034

Figure 7: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 2 SMA, 2025-2034

Figure 8: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2025-2034

Figure 9: Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 10: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Hospital Pharmacies, 2025-2034

Figure 11: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Retail Pharmacies, 2025-2034

Figure 12: Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2025-2034

Figure 13: Global Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Region, 2025 & 2034

Figure 14: North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2025 & 2034

Figure 15: North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2025

Figure 16: North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2025 & 2034

Figure 17: North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2025

Figure 18: North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2025 & 2034

Figure 19: North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 20: North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country, 2025 & 2034

Figure 21: North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country, 2025

Figure 22: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2025 & 2034

Figure 23: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2025

Figure 24: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2025 & 2034

Figure 25: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2025

Figure 26: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2025 & 2034

Figure 27: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 28: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 29: Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 30: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2025 & 2034

Figure 31: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2025

Figure 32: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2025 & 2034

Figure 33: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2025

Figure 34: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2025 & 2034

Figure 35: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 36: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 37: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 38: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2025 & 2034

Figure 39: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2025

Figure 40: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2025 & 2034

Figure 41: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2025

Figure 42: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2025 & 2034

Figure 43: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 44: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034

Figure 45: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 46: Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%), By Company, 2025

List of Tables

Table 1: Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2021-2034

Table 2: Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2021-2034

Table 3: Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034

Table 4: Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Region, 2025-2034

Table 5: North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2025-2034

Table 6: North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2025-2034

Table 7: North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2025-2034

Table 8: North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country, 2025-2034

Table 9: Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2025-2034

Table 10: Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2025-2034

Table 11: Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2025-2034

Table 12: Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2025-2034

Table 13: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2025-2034

Table 14: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2025-2034

Table 15: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2025-2034

Table 16: Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2025-2034

Table 17: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2025-2034

Table 18: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2025-2034

Table 19: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2025-2034

Table 20: Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2025-2034

Spinal Muscular Atrophy Treatment Market

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 120

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com